PURE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PURE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PURE Bioscience's Revenue per Share for the three months ended in Jan. 2024 was $0.00.
During the past 3 years, the average Revenue per Share Growth Rate was -40.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -9.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of PURE Bioscience was 77.70% per year. The lowest was -71.60% per year. And the median was -8.80% per year.
For the Household & Personal Products subindustry, PURE Bioscience's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
PURE Bioscience (OTCPK:PURE) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Thank you for viewing the detailed overview of PURE Bioscience's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert F Bartlett | director | 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730 |
Bernard Blotner | director | 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730 |
Tom Y Lee | director | 1807 SAN GABRIEL BLVD., SAN GABRIEL CA 91776 |
David Rendall | director | 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730 |
Kristin Taylor | director | 13500 EVENING CREEK DRIVE N, SUITE 550, SAN DIEGO CA 92128 |
Dale Okuno | director | 35 N. ARROYO PARKWAY, SUITE 1, PASADENA CA 91103 |
Ivan Chen | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Thomas Richard Myers | officer: Chief Operating Officer | 1725 GILLESPIE WAY, EL CAJON CA 92130 |
Henry R. Lambert | director, officer: Chief Executive Officer | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Elisabeth Hagen | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Janet Risi Field | director | 9200 SOUTH DADELAND BOULEVARD, SUITE 800, MIAMI FL 33156 |
Franchise Brands, Llc | 10 percent owner | 325 BIC DRIVE, MILFORD CT 06461 |
Mark Stuart Elliott | officer: Vice President, Finance | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
William Otis | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
David M Theno | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
From GuruFocus
By gurufocus 10qk • 12-15-2010
By gurufocus • 12-15-2008
By gurufocus • 03-13-2009
By [email protected] insider • 06-23-2020
By GuruFocus Research GuruFocus Editor • 06-30-2010
By gurufocus 10qk • 03-17-2011
By GuruFocus Research GuruFocus Editor • 12-28-2020
By PRNewswire PRNewswire • 11-02-2022
By [email protected] insider • 06-18-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.